ZBH or ESLOY: Which Is the Better Value Stock Right Now?

An analysis by Zacks identifies Zimmer Biomet (ZBH) as a superior value stock compared to EssilorLuxottica Unsponsored ADR (ESLOY), citing ZBH's Zacks Rank #2 (Buy) versus ESLOY's #3 (Hold) and a significantly better 'A' Value grade against ESLOY's 'D'. ZBH demonstrates more attractive valuation metrics, including a forward P/E of 12.80, PEG ratio of 2.40, and P/B ratio of 1.65, all substantially lower than ESLOY's respective figures of 38.31, 4.98, and 3.22, indicating a more favorable earnings outlook and potential undervaluation for value investors.

Analysis

A comparative analysis within the Medical Products sector identifies Zimmer Biomet (ZBH) as a superior value opportunity relative to EssilorLuxottica (ESLOY), based on a quantitative assessment of fundamentals and valuation. ZBH holds a Zacks Rank of #2 (Buy), indicating an improving earnings outlook driven by positive estimate revisions, whereas ESLOY is ranked #3 (Hold). The valuation disparity is stark: ZBH's forward P/E ratio is 12.80, substantially lower than ESLOY's 38.31. This discount is further supported by a PEG ratio of 2.40 and a Price-to-Book (P/B) ratio of 1.65 for ZBH, which are significantly more favorable than ESLOY’s respective metrics of 4.98 and 3.22. These factors culminate in ZBH earning a top-tier 'A' grade for Value in the Zacks Style Scores system, a stark contrast to ESLOY's 'D' grade, reinforcing the conclusion that ZBH presents a more compelling case for value-oriented investors at current levels.

Key Decisions for Investors

• Value-focused investors could consider initiating or adding to positions in Zimmer Biomet (ZBH), capitalizing on its strong 'A' value grade, a low forward P/E of 12.80, and positive earnings momentum reflected in its #2 (Buy) rank.
• Investors holding EssilorLuxottica (ESLOY) should be cautious of its high valuation, including a forward P/E of 38.31 and a PEG of 4.98, which contribute to its 'D' value grade and suggest potential underperformance relative to more attractively priced peers.
• A potential pairs trade strategy could be structured by going long ZBH and short ESLOY to capitalize on the significant valuation and fundamental disconnect identified between the two companies within the same sector.